BARDA Allocates $500 Million for Innovative COVID-19 Vaccine Trials
WASHINGTON, D.C. — The Biomedical Advanced Research and Development Authority (BARDA) has announced up to $500 million in funding under Project NextGen to advance clinical trials of novel COVID-19 vaccines …
BARDA Allocates $500 Million for Innovative COVID-19 Vaccine Trials Read More